TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.

Yoshiaki Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.